Psychemedics adds two directors, Kamin and Nevin, expands board to six at Aug. 12 annual meeting; Tomenson retires

PSYCHEMEDICS CORP

Board increases from 5 to 6 directors; Peter H. Kamin and Darius G. Nevin nominated for election at Aug. 12, 2022 annual meeting.
Walter S. Tomenson, Jr. will retire as director at the 2022 annual meeting after more than 20 years of service.
Cooperation Agreement with Kamin entities (beneficial owners of ~11.1% of PMD common stock) includes standstill until ~20 business days before 2023 annual meeting deadline.
Kamin and Nevin will serve on committees: Kamin on Compensation, Nominating, Strategic Alternatives; Nevin on Compensation, Audit, Strategic Alternatives.

item 1.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Walter S. Tomenson, Jr.

Director

PMDI · PSYCHEMEDICS CORP

Filed: June 9, 2022, 7:59 PM ET

On June 9, 2022, Walter S. Tomenson, Jr., a director of the Board notified the Company that he will be retiring from the Board at the 2022 Annual Meeting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Walter S. Tomenson, Jr. departed as Director at PSYCHEMEDICS CORP.

Action: retiring
Role: Director

Exact text from the filing

On June 9, 2022, Walter S. Tomenson, Jr., a director of the Board notified the Company that he will be retiring from the Board at the 2022 Annual Meeting.

View on SEC.gov

PSYCHEMEDICS CORP filing history →

Source: SEC EDGAR

accession 0001171843-22-004265

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.